190,197 Shares in Sotera Health Company $SHC Purchased by The Manufacturers Life Insurance Company

Key Points

• The Manufacturers Life Insurance Company bought 190,197 Sotera Health shares worth approximately $3.38 million, while other major institutions also increased positions. Institutional investors collectively own 91.03% of the company.
• Sotera Health beat quarterly expectations with $0.26 EPS and $321.38 million in revenue, up 9.2% year over year. Shares opened at $18.68, near their 52-week high of $19.85.
• Analysts maintain a generally positive outlook, with eight Buy ratings and an average price target of $21.50. However, insiders sold 1.29 million shares worth nearly $24 million over the past 90 days.

The Manufacturers Life Insurance Company bought a new position in Sotera Health Company (NASDAQ:SHC - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 190,197 shares of the company's stock, valued at approximately $3,376,000. The Manufacturers Life Insurance Company owned 0.07% of Sotera Health as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in SHC. BlackRock Inc. bought a new stake in shares of Sotera Health during the second quarter valued at about $428,635,000. Sculptor Capital LP boosted its position in shares of Sotera Health by 57.4% in the fourth quarter. Sculptor Capital LP now owns 21,000,000 shares of the company's stock valued at $370,440,000 after acquiring an additional 7,658,200 shares during the period. Two Seas Capital LP purchased a new position in Sotera Health during the second quarter valued at approximately $103,590,000. Sachem Head Capital Management LP grew its stake in Sotera Health by 47.2% during the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company's stock valued at $205,418,000 after acquiring an additional 3,735,000 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in Sotera Health by 16.7% during the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company's stock worth $339,189,000 after acquiring an additional 2,756,583 shares during the period. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $18.68 on Wednesday. The stock has a market cap of $5.33 billion, a PE ratio of 32.77 and a beta of 1.77. The company's fifty day moving average is $18.24 and its 200 day moving average is $16.42. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. Sotera Health Company has a 52 week low of $13.09 and a 52 week high of $19.85.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The company had revenue of $321.38 million during the quarter, compared to analysts' expectations of $309.70 million. During the same period in the prior year, the business posted $0.20 EPS. Sotera Health's quarterly revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Research analysts anticipate that Sotera Health Company will post 0.86 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have commented on SHC. Piper Sandler reissued an "overweight" rating and issued a $25.00 price target (up from $22.00) on shares of Sotera Health in a report on Friday, August 7th. The Goldman Sachs Group assumed coverage on Sotera Health in a research report on Friday, June 5th. They issued a "buy" rating and a $20.00 price objective on the stock. Citigroup lifted their price objective on Sotera Health from $23.00 to $25.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Weiss Ratings upgraded Sotera Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. Finally, JPMorgan Chase & Co. raised their price target on Sotera Health from $16.00 to $18.00 and gave the company a "neutral" rating in a report on Friday, August 7th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $21.50.

Insider Activity

In other news, insider Michael P. Rutz sold 150,000 shares of the stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. This represents a 30.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the company's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman directly owned 3,969,393 shares of the company's stock, valued at $73,433,770.50. The trade was a 17.64% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 1,294,515 shares of company stock valued at $23,999,528. Insiders own 15.36% of the company's stock.

Sotera Health Company Profile

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.